QMed, Inc.
QMED
$0.0001
$0.000.00%
| 02/29/2008 | 11/30/2007 | 08/31/2007 | 05/31/2007 | 02/28/2007 | |
|---|---|---|---|---|---|
| Revenue | -56.51% | -2,114.51% | 389.54% | 391.82% | -45.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -56.51% | -2,114.51% | 389.54% | 391.82% | -45.68% |
| Cost of Revenue | -54.77% | -11,496.20% | 1,024.95% | 390.34% | -61.50% |
| Gross Profit | -57.80% | 386.69% | -659.79% | 402.20% | -22.29% |
| SG&A Expenses | -17.09% | -300.98% | 1.33% | 12.20% | -35.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.94% | -1,724.48% | 253.10% | 124.14% | -41.91% |
| Operating Income | 10.35% | 1,208.46% | -167.11% | 11.61% | 37.37% |
| Income Before Tax | -475.11% | 1,304.17% | -177.52% | 11.66% | 115.95% |
| Income Tax Expenses | -70.18% | 89.71% | -123.53% | 229.41% | 111.61% |
| Earnings from Continuing Operations | -481.13% | 1,287.34% | -177.37% | 11.53% | 116.03% |
| Earnings from Discontinued Operations | 133.65% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.54% | 134.19% | -177.37% | 11.53% | 56.51% |
| EBIT | 10.35% | 1,208.46% | -167.11% | 11.61% | 37.37% |
| EBITDA | 10.64% | 1,485.59% | -173.60% | 11.95% | 38.85% |
| EPS Basic | 6.23% | 134.10% | -174.65% | 12.43% | 56.80% |
| Normalized Basic EPS | 6.68% | 1,378.06% | -174.76% | 12.54% | 36.80% |
| EPS Diluted | -1.66% | 133.56% | -174.65% | 12.43% | 58.32% |
| Normalized Diluted EPS | 0.55% | 1,378.06% | -174.76% | 12.54% | 40.69% |
| Average Basic Shares Outstanding | 0.76% | 0.94% | 0.98% | 1.05% | 0.63% |
| Average Diluted Shares Outstanding | -5.43% | 0.94% | 0.98% | 1.05% | 7.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
